Medical Materiel Quality Control (MMQC) & Army-Medical Materiel Instructions (MMI)
USAMMA's Distribution Operations Center (USAMMA DOC) primary focus with the DoD MMQC messages is to support the service specific logisticians, supply managers, and/or pharmacists in assuring the proper suspension of use, handling, and return of recalled materiel is accomplished. USAMMA DOC is responsible for disseminating MMQC on behalf of the Defense Logistics Agency in support of the combat combatant leaders, deployed service members and MHS registered customers.
MHS DMLSS USER: DHA MEDLOG has established the ECRI Hazard Alerts and Recalls (HAR) Notifications.
Customers with questions with regards to the HAR Notification process please contact the DHA-MEDLOG, Chief, Quality and Optimization Branch at 301-619-9851, DSN: 343-9851
Note: This is an informational page for the DOC MMQC/MMI Program. To access the MMQC/MMI Message search, subscription and POC information visit MMQC / MMI Message Response and Subscriber Management
USAMMA DOC creates, publishes, and distributes DoD-MMQC messages and Army-Medical Materiel Instructions (MMI) messages to subscribed customers for all medical materiel. These messages contain urgent information of system-wide interest, including:
Suspension of medical materiel
Extension of storage time periods (potency expiration dates) Disposition instructions Other significant quality control information
The MMQC program monitors and directs appropriate DoD action with respect to voluntary and involuntary medical product recalls, hazard alerts, and advisory notices to assure that the proper use, handling, and return of recalled product is accomplished to protect patient safety. Quality control data comes from pharmaceutical and/or medical device and equipment manufacturers regarding their products.
FDA recalls are classified as follows:
Class I: A situation in which there is a reasonable probability that the use of, or exposure to, a dangerous product will cause serious adverse health consequences or death.
Class II: A situation in which the use of, or exposure to, a dangerous product may cause adverse health consequences.
Class III: A situation in which the use of, or exposure to, a dangerous product is not likely to cause adverse health consequences.
Medical Logistics Policies
ECRI SUBSCRIPTION
Customer can request access and become a member of ECRI Institute to receive the Hazard Alerts and Recalls (HAR) notification.
Steps for Obtaining ECRI Access/Registration
1. Send an email to clientservices@ecri.org to request ECRI Access
2. ECRI will contact HAR Program Manager for requested access and approval. HAR Program Manager will contact user to confirm requested access. To obtain a copy of the ECRI User Registration Template contact DHA MEDLOG Quality and Optimization Branch at 301-619-9590. and submit the completed form to HAR Program Manager (For Facility include the facility name, this would allow placement under the correct facility)
3. Accept ECRI’s email invitation and follow directions on email to register (If you do not see the email in your inbox, please check you spam box)
4. Create an ECRI user account and set password to access membership
Note: Users can be set as FYI in the category selections, which allows them to receive the alerts without requiring them to track in Alerts Workflow.
See below for additional useful tips:
ECRI Institute Alert message user access has two types:
1. Alerts Tracking User
2. Facility Coordinator (administrative like privileges)
ECRI Institute Alert message user access has three product type options called Channels:
1. Medical Devices - which include medical consumable products and equipment
2. Pharmaceuticals
3. Medical Devices and Pharmaceuticals
ECRI Institute Alert message user access has four product type sub-types options called Categories:
1. Materiel Management
2. Clinical/Biomedical Engineering
3. Materiel Management and Clinical/Biomedical Engineering
4. Pharmacy
Access may take up to 24-48 hours once information is received.
ECRI INSTITUTE TRAINING GUIDES